Skip to main content
. Author manuscript; available in PMC: 2017 Jun 24.
Published in final edited form as: Pharmacogenet Genomics. 2016 Apr;26(4):154–160. doi: 10.1097/FPC.0000000000000201

Table 3.

Prevalence of the Metabolic Syndrome for the rs8050136 of the FTO gene

Participants with the Metabolic
Syndrome, no (%)
CC
(n = 66)
CA/AA
(n = 99)
P value*
3 criteria 26 (39.3) 27 (27.3)
4 criteria 19 (28.7) 25 (25.2)
5 criteria 5 (7.6) 8(8.1)
Total 50 (76.6) 60 (61.2) 0.02
*

Between-group difference in the proportions of participants with the Metabolic Syndrome, as calculated with the use of Chi-square test.